Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort

Simon et al. (Mon,) studied this question.

www.synapsesocial.com/papers/69d99ed49a6164e50fa3d165 — DOI: https://doi.org/10.1136/gutjnl-2021-325724

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study· 2010 · 117 citations
2. Design and validation of a histological scoring system for nonalcoholic fatty liver disease†· 2005 · 10,636 citations
3. The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months· 2006 · 1,858 citations
4. Statistical methods for studying disease subtype heterogeneity· 2015 · 270 citations
5. NAFLD-related mortality: simple hepatic steatosis is not as ‘benign’ as thought· 2020 · 32 citations